MAOIs and Other Antidepressants: Combination Dangers and Safer Alternatives

MAOIs and Other Antidepressants: Combination Dangers and Safer Alternatives

Combining MAOIs with other antidepressants can be life-threatening-if you don’t know what you’re doing. Monoamine oxidase inhibitors (MAOIs) like phenelzine, tranylcypromine, and the selegiline patch aren’t first-line treatments anymore. But for people with treatment-resistant depression, they’re often the last effective option left. The problem? One wrong move with another medication, and you could trigger serotonin syndrome-a condition that can spike your body temperature, lock your muscles, send your heart into chaos, and even kill you.

Why MAOIs Are Still Used

MAOIs were the first antidepressants ever developed, dating back to the 1950s. They work by blocking the enzyme that breaks down serotonin, norepinephrine, and dopamine. That means more of these mood-lifting chemicals stay active in your brain. For some people, especially those with atypical depression-think extreme fatigue, oversleeping, heavy limbs, and intense sensitivity to rejection-MAOIs work better than anything else. Studies show 40-60% of patients with treatment-resistant depression respond to MAOIs when other drugs failed.

The transdermal selegiline patch (Emsam) made MAOIs easier to use. At low doses (6 mg/24hr), it doesn’t require strict dietary changes. That’s why more psychiatrists are turning to it today. Still, most people avoid MAOIs because of the risks. And those risks aren’t theoretical. They’re documented in case reports, FDA warnings, and decades of clinical data.

The Deadly Mix: MAOIs and SSRIs/SNRIs

The most dangerous combination is MAOIs with SSRIs (like fluoxetine, sertraline) or SNRIs (like venlafaxine, duloxetine). Both types of drugs increase serotonin levels. Add them together, and your brain gets flooded. That’s serotonin syndrome.

A 1995 study in the Journal of Clinical Psychiatry looked at eight cases where fluoxetine was combined with tranylcypromine. Seven ended in death. The FDA responded with a boxed warning-the strongest type. It’s clear: never combine MAOIs with SSRIs or SNRIs.

Even timing matters. Fluoxetine sticks around in your system for up to five weeks because of its long-lasting metabolite, norfluoxetine. So if you stop fluoxetine, you still need to wait five weeks before starting an MAOI. For other SSRIs, it’s 14 days. The reverse is also true: if you’re coming off an MAOI, wait at least 14 days before starting any SSRI or SNRI. Rushing this window isn’t just risky-it’s reckless.

Tricyclic Antidepressants: A Gray Area

Tricyclics (TCAs) like amitriptyline or nortriptyline are older antidepressants. Historically, doctors were told to avoid combining them with MAOIs. But recent research is changing that.

A 2022 review in PMC9680847 found that combining MAOIs with certain TCAs isn’t automatically dangerous. In fact, some studies show good results. One trial with phenelzine and nortriptyline had a 57% response rate in treatment-resistant patients, with few serious side effects. The catch? You have to get the sequence right. If you start the MAOI first, the risk of serotonin syndrome goes up. But if you start the TCA first-or add them at the same time-the body adjusts better.

There’s one exception: clomipramine. This TCA is especially strong at blocking serotonin reuptake. Never combine it with an MAOI. The risk isn’t worth it.

So the rule isn’t “never.” It’s “only under expert supervision, with the right drug, and the right timing.” Nortriptyline is the safest TCA to consider. Amitriptyline? Riskier. Clomipramine? Absolutely not.

A psychiatrist guides a teen with glowing safe antidepressants floating protectively around them.

Safer Alternatives to Combine With MAOIs

You don’t need to risk serotonin syndrome to boost your antidepressant treatment. Several medications can be safely layered with MAOIs because they don’t strongly affect serotonin.

  • Bupropion (Wellbutrin): Works on dopamine and norepinephrine, not serotonin. It’s a top choice for people who need energy or struggle with sexual side effects from other meds.
  • Mirtazapine (Remeron): Blocks certain receptors to boost norepinephrine and serotonin-but in a way that doesn’t trigger dangerous spikes. Multiple case reports confirm it’s safe with MAOIs.
  • Trazodone: Used for sleep and depression. Low doses help with insomnia without increasing serotonin risk. Higher doses can be used for depression, still safely with MAOIs.
  • Nortriptyline: As mentioned, this TCA is the safest option when a second antidepressant is needed.
  • Pramipexole: A Parkinson’s drug that boosts dopamine. Used off-label for anhedonia and low motivation in depression. Case studies show it works well with MAOIs, though you need to start low and go slow to avoid nausea or dizziness.

Even benzodiazepines (like lorazepam) and sleep aids like zolpidem (Ambien) are safe to use alongside MAOIs. They don’t interfere with serotonin or cause hypertensive crises. If you’re anxious or can’t sleep, these are solid options.

What You Must Avoid

Beyond SSRIs and SNRIs, here are other dangerous interactions:

  • OTC cold medicines: Dextromethorphan (in cough syrups) can trigger serotonin syndrome.
  • St. John’s Wort: A natural supplement that acts like an SSRI. Never take it with an MAOI.
  • Tyramine-rich foods: Aged cheeses, cured meats, tap beer, soy sauce, and fermented foods can cause sudden, dangerous blood pressure spikes. The selegiline patch reduces this risk at low doses, but you still need to be careful. Avoid anything with more than 20mg of tyramine per 100g.
  • Other MAOIs: Combining two MAOIs is never safe. One is enough.

How to Transition Safely

Switching from one antidepressant to an MAOI isn’t a simple swap. It’s a carefully timed process.

  1. Stop your current antidepressant.
  2. Wait the full washout period: 5 weeks for fluoxetine, 14 days for all other SSRIs/SNRIs.
  3. Start the MAOI at the lowest dose.
  4. Monitor closely for side effects: headache, dizziness, high blood pressure, agitation.
  5. If adding a second medication (like bupropion or mirtazapine), wait at least a week after the MAOI is stable.

Never rush. Never guess. If your doctor says you can switch in a week after stopping fluoxetine, get a second opinion.

A person climbs a timeline bridge over withdrawal flames, with a rising sun of dopamine neurons above.

Stopping MAOIs Isn’t Easy Either

People think once you’re feeling better, you can just quit. But MAOIs cause a withdrawal syndrome that’s often worse than the depression.

Stopping suddenly can cause:

  • Restlessness (62% of cases)
  • Upset stomach (48%)
  • Tingling or burning skin (37%)
  • Flu-like symptoms (55%)
  • Severe sleep problems (71%)
  • Headaches (68%)

Always taper slowly-over 2 to 4 weeks. Work with your doctor. Don’t try to do it alone.

Why So Few Doctors Prescribe MAOIs

Only 5-10% of depression specialists regularly prescribe MAOIs. Why? Because most doctors aren’t trained in them. A 2019 study found only 32% of psychiatry residents felt confident managing MAOIs. Many learned about them in textbooks but never saw them in practice.

That’s a problem. MAOIs aren’t outdated-they’re underused. For the 15-20% of people who don’t respond to five or more other treatments, MAOIs are often the only thing that works. But if your doctor doesn’t know the rules, they’ll avoid them entirely.

The solution? Find a psychiatrist who specializes in treatment-resistant depression. Ask if they’ve prescribed MAOIs before. Ask about their experience with combinations. If they hesitate or say “it’s too risky,” they might not be the right fit.

The Future of MAOI Treatment

New research is making MAOIs safer and more targeted. Selective MAO-B inhibitors (like selegiline) are being studied for better side effect profiles. At Yale, early trials are testing MAOIs combined with ketamine for rapid relief in severe depression. These aren’t mainstream yet-but they’re coming.

For now, the key is precision: the right drug, the right timing, the right patient. MAOIs aren’t for everyone. But for those who’ve tried everything else, they can be life-changing-if used correctly.

Can I take SSRIs after stopping an MAOI?

Yes, but only after waiting at least 14 days after your last MAOI dose. If you were on fluoxetine before the MAOI, you must wait five weeks after stopping it before starting an MAOI. The reverse is true: if you’re switching from an MAOI to an SSRI, wait 14 days (or 5 weeks if the SSRI is fluoxetine) to avoid serotonin syndrome.

Is it safe to combine MAOIs with Wellbutrin?

Yes. Bupropion (Wellbutrin) doesn’t significantly affect serotonin levels-it works on dopamine and norepinephrine. Multiple clinical sources confirm it’s one of the safest antidepressants to combine with MAOIs. It’s often used to boost energy or counteract sexual side effects.

Can I drink alcohol while on an MAOI?

It’s best to avoid alcohol. While it doesn’t directly cause serotonin syndrome, alcohol can worsen side effects like dizziness, low blood pressure, and drowsiness. Some types, like red wine and tap beer, also contain tyramine and can trigger dangerous blood pressure spikes.

Do I need to follow a special diet forever on MAOIs?

No, not forever. If you’re on the selegiline patch at 6 mg/24hr or lower, dietary restrictions aren’t required. For oral MAOIs like phenelzine or tranylcypromine, you must avoid high-tyramine foods (aged cheese, cured meats, tap beer) while on the drug and for two weeks after stopping. The restriction isn’t lifelong-it’s temporary but critical.

What’s the most common mistake doctors make with MAOIs?

The biggest mistake is assuming all antidepressants are interchangeable. Many doctors don’t realize fluoxetine stays in the body for weeks, or that clomipramine is dangerous with MAOIs but nortriptyline isn’t. Another common error is rushing the washout period. Waiting isn’t optional-it’s what keeps you alive.

Are MAOIs still used today, or are they outdated?

They’re not outdated-they’re underused. MAOIs remain the most effective option for treatment-resistant depression, especially when other drugs have failed. The transdermal patch has made them easier to use. Experts agree: for the 15-20% of patients with truly refractory depression, MAOIs are often the only drug that works.

About Author
Anton Enright
Anton Enright

As a pharmaceutical expert, my passion lies in researching and understanding medications and their impact on various diseases. I have spent years honing my expertise in this field, working with renowned companies and research institutions. My goal is to educate and inform others through my writing, helping them make informed decisions about their health. I strive to provide accurate, up-to-date information on a wide range of medical topics, from common ailments to complex diseases and their treatments.